Pfizer’s Covid-19 antivirals reduce the risk of hospitalization or death in high-risk patients by up to 89%, according to final study results confirming previous data.
A drug candidate known as Paxlovid reduces the risk of hospitalization and death for standard-risk patients by 70%. The drug is most effective when first given within 3 days of onset of symptoms, but is 88% effective in high-risk patients within 5 days.
Results will come later Merck was I was forced to fix it Effective rate of that antiviral agent from 50 percent To 30 percent. The UK has approved Merck’s pills, but US regulators have not yet made a decision after scientific advisors voted slightly in favor.
Albert Bourla, Pfizer’s CEO, said the data are “further evidence” that antiviral candidates “have a significant impact on the lives of many.”
“New concerns like Omicron are Accessible treatment It’s an option for people infected with the virus, and if approved or approved, I’m confident that this potential treatment will be an important tool to help quell the pandemic, “he said.
Pfizer believes that antivirals are likely to retain their ability to tackle the Omicron variant of coronavirus, as they were able to address previous variants, including Delta. Early laboratory studies have shown continued efficacy against Omicron, and other studies are underway.
A US pharmaceutical company that is still increasing production says it will only have 180,000 courses available this year. We have raised our goal for next year to 80 million courses.
Final data on high-risk patients show that of the 697 people who received Paxrovid, only 5 were hospitalized and none died. In contrast, 44 patients who received placebo were hospitalized and 9 died.
In an interim analysis of standard-risk patients, 2 out of 333 patients who received the drug were hospitalized, compared with 8 in the placebo group. There were no deaths in either study group.
However, because the trial included only unvaccinated participants, there is no data on how the drug reduces the risk of vaccinated patients who are already at low risk of serious illness. ..
Pfizer drugs provide strong protection from Covid’s hospitalization or death, data confirm
Source link Pfizer drugs provide strong protection from Covid’s hospitalization or death, data confirm
The post Pfizer drugs provide strong protection from Covid’s hospitalization or death, data confirm appeared first on Eminetra.